Literature DB >> 18332802

Surviving blood loss without fluid resuscitation.

Christian Shults1, Elizabeth A Sailhamer, Yongqing Li, Baoling Liu, Malek Tabbara, Muhammad Umar Butt, Fahad Shuja, Marc Demoya, George Velmahos, Hasan B Alam.   

Abstract

BACKGROUND: Patients with massive blood loss often die before delivery of definitive care, especially in austere environments. Strategies that can maintain life during evacuation and transport to higher levels of care may be lifesaving. We have previously shown that administration of histone deacetylase inhibitors (HDACI) enhance gene transcription through specific modifications of DNA-associated histone proteins. Furthermore, it protects against organ damage when given before hemorrhage. The current experiment was done to test whether administration of HDACI after lethal hemorrhage, without fluid resuscitation, would improve outcome by creating a pro-survival phenotype.
METHODS: Seventy-two male Wistar-Kyoto rats (n = 12 per group) were subjected to 60% blood volume loss for 1 hour (40% arterial bleed for 10 minutes and 20% venous bleed for 50 minutes). After hemorrhage, animals were randomized to receive one of two HDACI: (1) valproic acid (VPA, 300 mg/kg in 0.25 mL saline), or (2) suberoyanilide hydroxamic acid (SAHA, 7.5 mg/kg in 0.25 mL saline). Control groups included (3) no hemorrhage (Sham), (4) no resuscitation (NR), (5) 0.9% saline resuscitation, 3 times the volume of shed blood (NS), and (6) vehicle control, 0.25 mL 0.9% saline (VEH). Hemodynamic data were recorded continuously, and physiologic parameters were measured serially. Survival for 3 hours was the primary endpoint for this experiment.
RESULTS: Nonresuscitated shock (NR group) was highly lethal and only 25% of the animals survived for 3 hours. Administration of HDACI after hemorrhage (without fluid resuscitation) significantly improved survival (75% and 83% in VPA and SAHA groups, respectively, p < 0.05 vs. NR). Survival was 40%, 100%, and 100% in the VEH, Sham, and NS resuscitation groups, respectively.
CONCLUSIONS: This study demonstrates that post-shock administration of HDACI can significantly improve early survival in a highly lethal model of hemorrhagic shock, even in the absence of conventional fluid resuscitation. This approach may be especially relevant for austere environments where fluids are in limited supply, such as a battlefield.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332802     DOI: 10.1097/TA.0b013e3181650ff3

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  26 in total

1.  Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.

Authors:  Yongqing Li; Hasan B Alam
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells.

Authors:  Nikolaos Zacharias; Elizabeth A Sailhamer; Yongqing Li; Baoling Liu; Muhammad U Butt; Fahad Shuja; George C Velmahos; Marc de Moya; Hasan B Alam
Journal:  Resuscitation       Date:  2010-10-30       Impact factor: 5.262

3.  Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.

Authors:  Ashley R Kochanek; Eugene Y Fukudome; Yongqing Li; Eleanor J Smith; Baoling Liu; George C Velmahos; Marc deMoya; David King; Hasan B Alam
Journal:  J Surg Res       Date:  2011-07-05       Impact factor: 2.192

4.  New trends in resuscitation.

Authors:  Hasan B Alam; George C Velmahos
Journal:  Curr Probl Surg       Date:  2011-08       Impact factor: 1.909

Review 5.  Creating a "Prosurvival Phenotype" Through Histone Deacetylase Inhibition: Past, Present, and Future.

Authors:  Ihab Halaweish; Vahagn Nikolian; Patrick Georgoff; Yongqing Li; Hasan B Alam
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

6.  Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1/2.

Authors:  Eugene Y Fukudome; Ashley R Kochanek; Yongqing Li; Eleanor J Smith; Baoling Liu; Tareq Kheirbek; Jennifer Lu; Kyuseok Kim; Kristopher Hamwi; George C Velmahos; Hasan B Alam
Journal:  J Surg Res       Date:  2010-05-07       Impact factor: 2.192

7.  Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.

Authors:  Robert A Finkelstein; Yongqing Li; Baoling Liu; Fahad Shuja; Eugene Fukudome; George C Velmahos; Marc deMoya; Hasan B Alam
Journal:  J Surg Res       Date:  2010-05-10       Impact factor: 2.192

8.  Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation.

Authors:  Aaron M Williams; Umar F Bhatti; Ben E Biesterveld; Nathan J Graham; Kiril Chtraklin; Jing Zhou; Isabel S Dennahy; Ranganath G Kathawate; Claire A Vercruysse; Rachel M Russo; Yongqing Li; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2019-08       Impact factor: 3.313

Review 9.  Advances in resuscitation strategies.

Authors:  Hasan B Alam
Journal:  Int J Surg       Date:  2010-09-15       Impact factor: 6.071

Review 10.  Histone Deacetylase Inhibitors: A Novel Strategy in Trauma and Sepsis.

Authors:  Aaron M Williams; Isabel S Dennahy; Umar F Bhatti; Ben E Biesterveld; Nathan J Graham; Yongqing Li; Hasan B Alam
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.